HomeTagsJohnson & Johnson MedTech

Johnson & Johnson MedTech

Biotechnology

New Data Published on Biosense Webster QDOT MICRO Catheter – the Latest Advancement in Focal RF Ablation for Treating AFib

PR Newswire - May 16, 2023

Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTech, announced that data from the Q-FFICIENCY study was...

Healthcare

DePuy Synthes Receives FDA Clearance for TELIGEN System

PR Newswire - October 21, 2022

Johnson & Johnson MedTech announced that DePuy Synthes, The Orthopaedics Company of Johnson & Johnson, has secured 510(k) clearance from the U.S. Food and...